Do Randomized Clinical Trials Always Provide Certain Results? The Case of Tralokinumab in Idiopathic Pulmonary Fibrosis

Am J Respir Crit Care Med. 2018 Jan 1;197(1):9-10. doi: 10.1164/rccm.201708-1666ED.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Randomized Controlled Trials as Topic

Substances

  • Antibodies, Monoclonal
  • tralokinumab